|
⚲
|
| Keyboard |
| Vaxcyte Inc | |
|---|---|
| Ticker | PCVX |
| CIK # | 0001649094 |
| CUSIP | 92243G108 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 353 Hatch Dr, Foster City, CA 94404 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Sutrovax Inc | 2020-04-03 | 110.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001649094] | 10-K | |
| [0001649094] | 10-Q | |
| [0001649094] | 3 | |
| [0001649094] | 4 | |
| [0001649094] | 8-K | |
| [0001649094] | D | |
| [0001649094] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Vanguard Capital Management LLC | Vaxcyte Inc | [2026-04-30] | 0.0 |
| T Rowe Price Investment Management Inc | Vaxcyte Inc | [2025-11-14] | 0.0 |
| BlackRock Inc | Vaxcyte Inc | [2023-02-03] | 6.5 |
| Vanguard Group Inc | Vaxcyte Inc | [2022-02-10] | 5.94 |
| BlackRock Inc | Vaxcyte Inc | [2022-02-04] | 5.3 |
| Roche Finance Ltd | Vaxcyte Inc | [2021-02-16] | 5.1 |
| Abingworth LLP | Vaxcyte Inc | [2021-02-16] | 8.2 |
| Longitude Capital Partners II LLC | Vaxcyte Inc | [2021-02-12] | 6.1 |
| Janus Henderson Group PLC | Vaxcyte Inc | [2021-02-12] | 8.2 |
| FMR LLC | Vaxcyte Inc | [2020-08-10] | 0.0 |
| RA Capital Management LP | Vaxcyte Inc | [2020-07-10] | 10.8 |
| TPG Group Holdings SBS Advisors Inc | Vaxcyte Inc | [2020-06-26] | 10.2 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cowan Elvia
Common Stock
|
2026-03-17 | Sell | 405 | $56.26 | 22,785 |
|
Cowan Elvia
Common Stock
|
2026-03-17 | Sell | 1,487 | $55.39 | 82,365 |
|
Cowan Elvia
Common Stock
|
2026-03-11 | Sell | 2,500 | $58.59 | 146,475 |
|
Cowan Elvia
Stock Option (right to buy) · derivative
|
2026-03-11 | Option exercise | 2,500 | $0.00 | |
|
Cowan Elvia
Common Stock
|
2026-03-11 | Option exercise | 2,500 | $25.92 | 64,800 |
|
Wassil Jim
Common Stock
|
2026-03-10 | Sell | 2,427 | $58.32 | 141,543 |
|
Wassil Jim
Common Stock
|
2026-03-10 | Sell | 4,968 | $59.16 | 293,907 |
|
Wassil Jim
Common Stock
|
2026-03-09 | Tax withheld | 975 | $59.32 | 57,837 |
|
Pickering Grant
Common Stock
|
2026-03-09 | Tax withheld | 3,685 | $59.32 | 218,594 |
|
Guggenhime Andrew
Common Stock
|
2026-03-09 | Tax withheld | 1,021 | $59.32 | 60,566 |
|
Dhaliwal Harpreet S
Common Stock
|
2026-03-09 | Tax withheld | 604 | $59.32 | 35,829 |
|
Cowan Elvia
Common Stock
|
2026-03-09 | Tax withheld | 495 | $59.32 | 29,363 |
|
Dhaliwal Harpreet S
Common Stock
|
2026-03-02 | Tax withheld | 465 | $61.98 | 28,821 |
|
Cowan Elvia
Common Stock
|
2026-03-02 | Tax withheld | 326 | $61.98 | 20,205 |
|
Guggenhime Andrew
Common Stock
|
2026-03-02 | Tax withheld | 1,009 | $61.98 | 62,538 |
|
Pickering Grant
Common Stock
|
2026-03-02 | Tax withheld | 2,531 | $61.98 | 156,871 |
|
Wassil Jim
Common Stock
|
2026-03-02 | Tax withheld | 1,009 | $61.98 | 62,538 |
|
Cowan Elvia
Common Stock
|
2026-02-28 | Tax withheld | 243 | $61.98 | 15,061 |
|
Pickering Grant
Common Stock
|
2026-02-28 | Tax withheld | 2,863 | $61.98 | 177,449 |
|
Guggenhime Andrew
Common Stock
|
2026-02-28 | Tax withheld | 898 | $61.98 | 55,658 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 339 | 151,807,498 |
| 2025-12-31 | 298 | 135,348,535 |
| 2025-09-30 | 290 | 133,055,614 |
| 2025-06-30 | 295 | 138,768,829 |
| 2025-03-31 | 320 | 139,952,137 |
| 2024-12-31 | 324 | 134,139,959 |
| 2024-09-30 | 331 | 130,564,007 |
| 2024-06-30 | 270 | 117,096,093 |
| 2024-03-31 | 256 | 115,220,323 |
| 2023-12-31 | 228 | 100,711,219 |
| 2023-09-30 | 204 | 97,858,104 |
| 2023-06-30 | 202 | 97,236,570 |